Catalysis by the serine proteinases proceeds via a tetrahedral intermediate whose oxyanion is stabilized by hydrogen-bonding in the oxyanion hole. There have been extensive 13 C-NMR studies of oxyanion and tetrahedral intermediate stabilization in trypsin, subtilisin and chymotrypsin using substrate-derived chloromethane inhibitors. One of the limitations of these inhibitors is that they irreversibly alkylate the active-site histidine residue which results in the oxyanion not being in the optimal position in the oxyanion hole. Substrate-derived glyoxal inhibitors are reversible inhibitors which, if they form tetrahedral adducts in the same way as substrates form tetrahedral intermediates, will overcome this limitation. Therefore we have synthesized 13 C-enriched substrate-derived glyoxal inhibitors which have allowed us to use 13 C-NMR and 1 H-NMR to determine how they interact with proteinases. It is hoped that these studies will help in the design of specific and highly potent warheads for serine proteinase inhibitors.
Introduction
Catalysis by the serine proteases is thought to involve binding of a peptide substrate followed by addition of an active-site serine hydroxy group to a substrate peptide carbonyl carbon to form a tetrahedral intermediate [1] [2] [3] . This intermediate can then revert to starting materials or proceed to form an acyl intermediate by expelling the amino acid that provides the nitrogen of the peptide bond being cleaved. The acyl intermediate is then hydrolysed via a second tetrahedral intermediate to yield free enzyme and the second product. With natural substrates, it is the formation and/or breakdown of the first tetrahedral intermediate which is thought to be the ratelimiting step in catalysis. Proteolytic enzymes are thought to achieve their remarkable catalytic efficiency by transitionstate stabilization of tetrahedral intermediate formation and or breakdown. Inhibitors which mimic this tetrahedral intermediate should be tightly bound by the enzyme. Therefore it is not surprising that many proteinase inhibitors have been designed with warheads which either mimic the catalytic tetrahedral intermediate or are able to react with the active-site serine hydroxy group in serine proteinases to form tetrahedral adducts similar to the catalytic tetrahedral intermediate.
Tetrahedral intermediates are expected to be extremely unstable with very short lifetimes and they are expected to be energetically close to the transition state of the reaction. Although it would not appear feasible to observe true catalytic tetrahedral intermediates, there have been numerous attempts to observe them. Some early attempts to use cryoenzymological techniques to observe tetrahedral intermediates have been criticized [4] . Early X-ray crystallographic studies [5, 6] led to the claim that soya bean and bovine pancreatic trypsin inhibitors formed a tetrahedral adduct with trypsin [3] . However, 13 C-NMR studies did not substantiate this claim [7] [8] [9] .
Therefore a sensible and widely adopted approach which is used to study how enzymes form and stabilize tetrahedral intermediates is to study the binding of inhibitors which act as transition-state analogues mimicking the tetrahedral intermediate. Halomethanes were first developed as specific irreversible inhibitors of chymotrypsin [10] . The chloromethyl group alkylated the active-site histidine residue [10] . Kezdy et al. [11] first suggested that the alkylation reaction may be preceded by formation of a tetrahedral intermediate, and it was on the basis of X-ray crystallographic data that it was claimed that a tetrahedral adduct was also formed [12] . 13 C-NMR can show whether a tetrahedral adduct is formed, because, if it is, the chemical shift of the chloromethane carbonyl carbon will change from ∼200 p.p.m. to 100 p.p.m. as the carbon hybridization changes from sp 2 to sp 3 . In this way, 13 C-NMR has been used to show that peptide-derived chloromethane inhibitors, in addition to alkylating the active-site histidine residue, also form tetrahedral adducts with chymotrypsin [13, 14] , subtilisin [15, 16] and trypsin [17, 18] . These stable tetrahedral hemiketals have allowed 13 C-NMR to be used [15, 16] to show that the oxyanion pK a is lowered ∼2 pK a units more in subtilisin than in chymotrypsin (Table 1) .
Oxyanion hole in chloromethane inhibitor adducts with chymotrypsin and subtilisin
It was Henderson in 1970 [19] who, on the basis of X-ray crystallographic data with chymotrypsin, suggested that there were hydrogen bonds from the backbone amide groups of Ser 195 and Gly 193 to the substrate carbonyl. He also suggested that these hydrogen bonds could fix the substrate carbonyl in position and favour tetrahedral intermediate formation.
However, it was X-ray crystallographic studies on subtilisin that led to the first use of the terms oxyanion and oxyanion hole [20] when describing the transition-state stabilization of tetrahedral intermediates by the serine proteases. There is considerable interest in determining how the oxyanion hole contributes to oxyanion stabilization [16, [21] [22] [23] [24] . X-ray crystallographic studies are limited by the fact that they cannot distinguish between the oxyanion and its conjugate acid and so they cannot be used to determine oxyanion pK a values and so quantify oxyanion stabilization [25] . However, 13 C-NMR has proved to be a powerful tool for detecting oxyanion formation and determining the pK a values of oxyanions [14, 15, 18] .
In chymotrypsin, both hydrogen-bonding groups are backbone amide groups and so site-directed mutagenesis cannot be used to remove any of these groups. However, in subtilisin, one of the hydrogen-bond donors to the oxyanion is the side-chain amide NH 2 group of Asn 155 . Converting this residue into an alanine residue raised the oxyanion pK a by only 1.09 pK a units. Therefore the two hydrogen-bonding amide groups in chymotrypsin should only reduce the oxyanion pK a by ∼2.2 pK a units. However, water is a good hydrogen-bonding solvent and would be expected to lower the oxyanion pK a by a similar amount. This led to the conclusion that hydrogen-bonding in the oxyanion hole does not make a major contribution to lowering the oxyanion pK a relative to its value in water [24] .
X-ray crystallographic studies of chymotrypsin inhibited by a peptide-derived chloromethane inhibitor [26] showed that the hydrogen bonds to the oxyanion were slightly longer [0.18 and 0.65 Å (1 Å = 0.1 nm)] than those observed with inhibitors which did not alkylate the active-site histidine residue [27] . This suggested that, owing to alkylation of the activesite histidine residue, hydrogen-bonding to the oxyanion may not be optimal in chloromethane inhibitor adducts. Peptidederived trifluoromethane inhibitors of chymotrypsin form good structural analogues of tetrahedral intermediates, but the extremely electronegative fluorine substituents give the oxyanion a very low pK a which could not be measured [28] and so they are not suitable for quantifying oxyanion stabilization. Therefore we have used substrate-derived glyoxal inhibitors to study tetrahedral intermediate and oxyanion stabilization in chymotrypsin and subtilisin.
Substrate-derived glyoxal inhibitors
Glyoxals or α-keto-β-aldehydes (RCOCHO) are reactive compounds which have been used as radiosensitizers of cells [29] and as arginine reactivity probes [30] .
Specific substrate-derived glyoxal inhibitors of proteases have been synthesized [31] and shown to be potent reversible inhibitors of chymotrypsin [32] [33] [34] [35] , subtilisin [36] , papain [37] , cathepsin B [35, 38] , cathepsin L [38] , cathepsin S [39] and the proteasome [40] . In substrate-derived glyoxal inhibitors, the peptide carboxy group (RCOOH) is replaced by a glyoxal or keto-aldehyde group (RCOCHO) and the α-keto carbon of the glyoxal should occupy the same position as the hydrolysed peptide carbonyl of a peptide substrate. Figure 1 (Structures 1a and 1b) . When the glyoxal inhibitor with its keto carbon 13 C-enriched is added to chymotrypsin at pH 3, the free inhibitor signals at 206.8 and 96.5 p.p.m. were replaced by a new signal at 100.7 p.p.m. This new signal at 100.7 p.p.m. was assigned to the hemiketal carbon of a tetrahedral adduct formed by the reaction of the hydroxy group of Ser 195 and the 13 C-enriched keto group of the glyoxal inhibitor [33] (Structure 2 in Figure 1 ). On increasing the pH, the signal at 100.7 p.p.m. (Structure 2 in Figure 1 ) titrated in a fast-exchange process to ∼104 p.p.m. (Structure 3 in Figure 1 ) with a pK a of 5 and its intensity decreased as the intensity of a new signal at 107 p.p.m. (Structure 5 in Figure 1 ) was formed in a slow-exchange process with a pK a ∼4. Using inhibitor enriched in the aldehyde carbon, it was shown that the aldehyde group dehydrated when the hemiketal oxyanion was formed (Structure 5 in Figure 1 ). The fast-exchange process with a pK a of 5 was assigned to formation of the hemiacetal oxyanion (Structure 3 in Figure 1 ) and the slow-exchange process with a pK a of ∼4 was assigned to formation of the hemiketal oxyanion (Structure 5 in Figure 1 ) [33] . Recent studies have shown that the aldehyde carbon rehydrates as the pH increases (Structures 5 and 3 in Figure 1 ) [32] . This is expected because the hydration of aldehyde groups is acid-base-catalysed [41] .
C-NMR of glyoxal inhibitors bound to subtilisin
When Z-Ala-Pro-Phe-glyoxal (where Z is benzyloxycarbonyl) is added to subtilisin, only Structure 5 in Figure 1 was observed, and there was no evidence for protonation of this species at pH 4, demonstrating that in subtilisin the hemiketal oxyanion pK a is <3 [36] . This shows that, with both reversible glyoxal and irreversible chloromethane inhibitors, oxyanion stabilization is more effective in subtilisin than in chymotrypsin. From these results, it was estimated that the oxyanion pK a would be ∼2.5 and ∼4.5 in catalytic tetrahedral intermediates formed by subtilisin and chymotrypsin respectively. As the rate-limiting step in catalysis occurs with a pK a of ∼7, it is clear that oxyanion formation is not rate-limiting in catalysis.
Binding of Z-Ala-Pro-Phe-glyoxal to subtilisin and chymotrypsin Z-Ala-Pro-Phe-glyoxal is a potent competitive inhibitor of α-chymotrypsin with an apparent disassociation constant of 25 ± 8 nM at pH 7.0 [33] . At pH 7, this inhibitor was bound ∼200-fold less tightly by subtilisin [36] . When disassociation constants are >1 mM, then the free and bound inhibitor are expected to be in fast exchange and they should be represented by a single averaged signal. This did not happen with subtilisin, showing that the free and bound inhibitor were in slow exchange. From the lack of slow-exchange broadening, it was estimated that the rates of formation (k on ) of hemiketals (Structure 2 in Figure 1 ) must be less than 5 × 10 5 M −1 · s −1 at pH 4.75 and 6.99. Therefore, while noncovalent binding of glyoxal inhibitors to subtilisin is most probably diffusion-controlled (∼10 8 M −1 · s −1 ), the formation of the hemiketal species involves covalent bond formation and is much slower. Using surface plasmon resonance [32] , it was shown that, with α-chymotrypsin, the rate of association (k on = 4.8 × 10 5 M −1 · s −1 ) was also significantly less than the diffusion-controlled limit (
. This means that, with glyoxal inhibitors, NMR can be used to observe enzyme complexes even when binding is weak.
Effect of replacing the proline residue in Z-Ala-Pro-Phe-glyoxal with an alanine residue Z-Ala-Pro-Phe-glyoxal can exist in both cis and trans forms, but only one form is bound by chymotrypsin and this is thought to be the trans form of the inhibitor [33] . Replacing the proline residue in Z-Ala-Pro-Phe-glyoxal with an alanine residue to give Z-Ala-Ala-Phe-glyoxal decreased binding 10-fold [32] . This suggests that binding a more rigid prolinecontaining peptide significantly improves binding, presumably due to entropic effects.
Effect of pH on the K d values for glyoxal inhibitors binding to chymotrypsin
Disassociation constants were minimal at neutral pHs, but increased with a pK a of ∼4 which was essentially the same pK a as that for hemiketal oxyanion formation (Structure 5 in Figure 1 ), suggesting that oxyanion formation improves binding [33] . K d values also increased at high pHs according to a pK a value of ∼10.6. This pK a was assigned to a conformational change caused by the ionization of the Ile ion pair [32] whose pK a is raised from ∼8.8 [42] to ∼10.5 [43] on binding ligands. K d values only increased to <2 µM at high pH, and so the NMR samples which contained 1-2 mM chymotrypsin were fully saturated with glyoxal inhibitors at alkaline pH, allowing NMR studies at alkaline pH.
H-NMR of the hydrogen-bonded protons in chymotrypsin
With free α-chymotrypsin at 4
• C, the signal at ∼18 p.p.m. due to the N δ1 proton of His 57 titrated to ∼15 p.p.m. with a pK a of ∼7 [32, 44] . When either Z-Ala-Pro-Phe-glyoxal or Z-Ala-Ala-Phe-glyoxal were bound to α-chymotrypsin at pH ∼3.5 and 25
• C, signals at ∼18 and ∼13 p.p.m. were observed which were assigned to the His 57 N δ1 proton hydrogen-bonded to Asp 102 and the His 57 N 2 protons respectively [32] (Figure 2 ). These signals were present at pH ∼11, confirming that the binding of the glyoxal inhibitors raised the pK a of the imidazolium ion of the active-site histidine residue to >11. Mutations converting Asp 102 into neutral alanine or asparagine residues inactivated the enzyme [45] [46] [47] , while converting it into a negatively charged cysteine residue only led to a small decrease in catalytic efficiency [48] . This supports the suggestion that it is the electrostatic interaction between Asp 102 and His 57 which is the major factor in raising the pK a of His 57 [14] . In chloromethane adducts with chymotrypsin, it has been shown that oxyanion formation caused a small titration on the N δ1 proton of His 57 [44] . With glyoxal inhibitors, both hemiketal and hemiacetal oxyanion formation caused similar small titration shifts for the N δ1 proton at ∼18 p.p.m. [32] .
Conclusions
It is clear that both irreversible chloromethane inhibitors and reversible glyoxal inhibitors are powerful tools for studying the stabilization of tetrahedral intermediates and their oxyanions. Oxyanion stabilization is more effective in glyoxal inhibitor complexes, suggesting that these tetrahedral adducts closely resemble catalytic tetrahedral intermediates. Our results show that the binding of glyoxal inhibitors raises the pK a of the active-site histidine residue of chymotrypsin from ∼7 to a value >11. Therefore it is expected that substrate binding will also raise the pK a of His 57 , allowing it to be an effective general base catalyst for deprotonation of the hydroxy group of the active serine residue, promoting tetrahedral intermediate formation during catalysis. Raising the pK a of His 57 by ligand binding will also promote oxyanion stabilization which results in the formation of a zwitterionic tetrahedral adduct with glyoxal inhibitors that mimics the zwitterionic tetrahedral intermediate formed during catalysis. It is concluded that hydrogen-bonding in the oxyanion hole only has a minor role in lowering the pK a of the oxyanion and that it is the electrostatic interaction between the oxyanion and the imidazolium ion of His 57 that is the major factor in lowering the pK a of the oxyanion. Also, it is clear that if the energy used for oxyanion stabilization is utilized as binding energy by drugs then it could make a significant contribution to inhibitor specificity and potency [36] . We have undertaken similar studies on the cysteine proteinases [37] and we are currently extending these studies to the aspartyl-and metallo-proteinases.
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